Press Releases

Year

Feb 2012

LifeVantage Spokesperson, Donny Osmond, Appears on Dr. Phil

Protandim Ranks First Among U.S. Google Searches

PDF Version

Feb 2012

LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012

SALT LAKE CITY , Feb. 7, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today it will release financial results for the second quarter ended December 31, 2011 , after the market closes on Tuesday,

PDF Version

Jan 2012

LifeVantage Expands Board of Directors and Announces Approval of Tender Offer to Modify Warrants

Nine Directors Including Four New Directors Elected at Company's Annual Meeting of Shareholders Board Appoints New Chairman SALT LAKE CITY , Jan. 17, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced that

PDF Version

Jan 2012

LifeVantage to Present at 14th Annual ICR XChange

SALT LAKE CITY , Jan. 4, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson , the Company's President and Chief Executive Officer, will be presenting at the 14th Annual ICR

PDF Version

Dec 2011

LifeVantage Provides Corporate Update

Announces Adoption of Rule 10b5-1 Stock Repurchase Plan Anticipates Approval of Warrant Amendment to Remove Price-Based Anti-dilution Provisions Outlines Operational & Strategic Accomplishments and Guidance for 2012 SALT LAKE CITY , Dec. 19, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation

PDF Version

Nov 2011

LifeVantage to Present at Wedbush 12th Annual California Dreamin' Conference

SALT LAKE CITY , Nov. 30, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson , the Company's President and Chief Executive Officer, and Carrie McQueen , the Company's Chief

PDF Version

Nov 2011

LifeVantage Announces Record First Quarter Fiscal Year 2012 Results

Net Revenue Increases Over 200% from the Prior Year Period to $20.1 Million Operating Income Improves to a Record $3.4 Million or 17% Operating Margin Company Raises Full Year Fiscal 2012 Revenue and Operating Margin Guidance SALT LAKE CITY , Nov. 14, 2011 (GLOBE NEWSWIRE) -- LifeVantage

PDF Version

Nov 2011

LifeVantage Announces New Peer-Reviewed Study Involving Protandim(R)

Published in Scientific Journal Molecular Aspects of Medicine

PDF Version

Nov 2011

LifeVantage to Announce Fiscal First Quarter 2012 Results on November 14, 2011

SALT LAKE CITY , Nov. 7, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today it will release financial results for the fiscal first quarter ended September 30, 2011 , after the market closes on

PDF Version

Sep 2011

LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance

Record Fourth Quarter Net Revenue Increases to $15.0 Million
Generates Record Full Year Fiscal 2011 Operating Income of $3.7 Million
Company Strengthens Balance Sheet and Ends Fiscal 2011 with No Convertible Debt
Company Expects Fiscal Year 2012 Revenue and Operating Income to Increase Over 100%

PDF Version

Pagination

First page
Previous page
…
Page 26
Page 27
Page 28
Page 29
Current page 30
Page 31
Page 32
Page 33
Page 34
…
Next page
Last page